Showing results (1-10 of 86) with videos related to
Sort By:
Pageof 9
JAMA Network Open|March 15, 2022
Cancer Drug Approvals That Displaced Existing Standard-of-Care Therapies, 2016-2021David J Benjamin, Alexander Xu, Mark P Lythgoe, et al.Trends in Cancer|April 7, 2024
The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulationsMatthew J Hadfield, David J Benjamin, Jonathan Krell, et al.Prostate Cancer and Prostatic Diseases|October 5, 2023
Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registryDavid J Benjamin, Anshu Shrestha, Dimitra Fellman, et al.Trends in Pharmacological Sciences|April 16, 2020
Ongoing Clinical Trials for the Management of the COVID-19 PandemicMark P Lythgoe, Paul MiddletonBritish Journal of Cancer|June 23, 2022
Repositioning canakinumab for non-small cell lung cancer-important lessons for drug repurposing in oncologyMark P Lythgoe, Vinay PrasadJournal of Immunology Research|September 18, 2015
Application of "Systems Vaccinology" to Evaluate Inflammation and Reactogenicity of Adjuvanted Preventative VaccinesDavid J M Lewis, Mark P LythgoeEuropean Journal of Cancer (Oxford, England : 1990)|November 4, 2021
The iceberg plot, improving the visualisation of therapy response in oncology in the era of sequence-directed therapyMark P Lythgoe, Timothée Olivier, Vinay PrasadBMJ Open Gastroenterology|October 22, 2021
Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studiesPaul Middleton, Catherine Hsu, Mark P LythgoeExpert Opinion on Pharmacotherapy|October 8, 2020
Advances in cyclin-dependent kinase inhibitors for the treatment of melanomaMaximilian Julve, James J Clark, Mark P LythgoeCancers|August 27, 2021
Exploring the Epigenome in Gastroenteropancreatic Neuroendocrine NeoplasiasRohini Sharma, Mark P Lythgoe, Bhavandeep Slaich, et al.Pageof 9